Market Place
Sourcing Support
FDA Eliminates Risk Evaluation, Mitigation for Car-T Therapies
28 Jun 2025 //
REUTERS
FDA Updates Bristol Myers Squibb Cell Therapy Label, Removes REMS
26 Jun 2025 //
BUSINESSWIRE
Biogen, BMS and Novartis bag spots on Cannes Lions shortlists
16 Jun 2025 //
FIERCE PHARMA
BMS Taps Biotech Analyst to Lead Long-Term Strategy
13 Jun 2025 //
FIERCE BIOTECH
Bristol Myers Squibb to Report Q2 2025 Results on July 31, 2025
12 Jun 2025 //
BUSINESSWIRE
BMS Shows CELMoD BCL6 Degrader Data at EHA 2025
12 Jun 2025 //
BUSINESSWIRE
Bristol Myers CEO Stays Bullish on Cobenfy despite trial flop
12 Jun 2025 //
FIERCE PHARMA
BMS`s Deucravacitinib Shows Superiority in Psoriatic Arthritis
12 Jun 2025 //
BUSINESSWIRE
RayzeBio bags Philochem’s Cancer Radiotracer in $1.35B deal
11 Jun 2025 //
GLOBENEWSWIRE
FDA limits Merck`s Keytruda, BMS` Opdivo in Stomach Cancer
10 Jun 2025 //
FIERCE PHARMA
Markey Researchers Get $6.8M For Lung Cancer Screening Model
06 Jun 2025 //
ACCESSWIRE
ASCO: Bristol CMO brushes off LAG-3 concern after melanoma flop
03 Jun 2025 //
FIERCE PHARMA
Bristol Myers Squibb gets EU approval for Opdivo Subcutaneous
28 May 2025 //
BUSINESSWIRE
BMS to Join Goldman Sachs Global Healthcare Conference
28 May 2025 //
BUSINESSWIRE
BMS`s Biologics Yervoy Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Qvantig Receives Suppl Approval in US
23 May 2025 //
FDA
Bristol Myers Squibb to Present Data at ASCO® 2025
22 May 2025 //
BUSINESSWIRE
Bristol Myers Squibb at Bernstein 41st Annual Strategic Decisions
21 May 2025 //
BUSINESSWIRE
Tubulis Hits Milestone in BMS License as Tubutecan ADC
20 May 2025 //
GLOBENEWSWIRE
Bristol Myers gets EU approval for Opdivo regimen in lung Cancer
16 May 2025 //
BUSINESSWIRE
Hawaii settles for $700 million with Bristol-Myers, Sanofi
12 May 2025 //
REUTERS
BMS`s Augtyro Receives Approval in Canada
07 May 2025 //
HEALTH CANADA
Strengthening Local Health System Capacity for Better Care
07 May 2025 //
ACCESSWIRE
2seventy bio Reports Q1 Results, Update on BMS Acquisition
07 May 2025 //
BUSINESSWIRE
Bristol Myers Squibb Names Cari Gallman EVP, General Counsel & CPO
06 May 2025 //
BUSINESSWIRE
BMS prunes NJ workforce again, this time to tune of 500+ jobs
06 May 2025 //
FIERCE PHARM
Bristol Myers to invest $40 billion in the US over 5 years
06 May 2025 //
REUTERS
BMS to Close Libertyville Viral Vector Production Facility
02 May 2025 //
CONTRACTPHARMA
BMS Reports Mixed Earnings as Portfolio due to Generic Pressure
26 Apr 2025 //
BIOSPACE
Bristol Myers Squibb`s Q1 2025 Financial Results Reported
24 Apr 2025 //
BUSINESSWIRE
BMS Cobenfy fails in key study as add-on treatment for schizophrenia
23 Apr 2025 //
PRESS RELASE
FDA Updates Camzyos Label to Reduce Monitoring Requirements
17 Apr 2025 //
BUSINESSWIRE
OpenFold AI Research Consortium Welcomes New Members
15 Apr 2025 //
BUSINESSWIRE
BMS` heart disease drug fails to meet main goals in study
15 Apr 2025 //
PRESS RELEASE
BMS`s Biologic Yervoy Receives Suppl Approval in US
11 Apr 2025 //
FDA
BMS`s Biologic Opdivo Receives Suppl Approval in US
11 Apr 2025 //
FDA
FDA approves Opdivo and Yervoy for Hepatocellular Carcinoma
11 Apr 2025 //
BUSINESSWIRE
Bristol Myers wins dismissal of lawsuit alleging Pomalyst monopoly
09 Apr 2025 //
REUTER
FDA approves Opdivo & Yervoy for untreated colorectal cancer
08 Apr 2025 //
BUSINESSWIRE
Halozyme: BMS Gets CHMP Nod For Subcutaneous Opdivo
31 Mar 2025 //
PR NEWSWIRE
Bristol Myers Gets Positive CHMP Opinion for Opdivo Subcutaneous
28 Mar 2025 //
BUSINESSWIRE
Bristol Myers Squibb Gets CHMP Nod for Opdivo in Lung Cancer
28 Mar 2025 //
BUSINESSWIRE
BMS Appoints Osama Braiwish As GM For Saudi, Gulf Region
20 Mar 2025 //
PR NEWSWIRE
Bristol Myers Squibb gets EU approval to expand Breyanzi
14 Mar 2025 //
BUSINESSWIRE
Bristol Myers Squibb to Report Q1 2025 Results on April 24
13 Mar 2025 //
BUSINESSWIRE
2seventy bio Enters into Agreement to be Acquired by BMS
11 Mar 2025 //
BUSINESSWIRE
BMS Presents Ph3 Data Showing Sotyktu Superiority in Psoriatic Arthritis
10 Mar 2025 //
BUSINESSWIRE
BMS` Sotyktu Superior In Ph3 POETYK PsA-2 Psoriatic Study
08 Mar 2025 //
BUSINESSWIRE
BMS Gets EU Nod For Opdivo+Yervoy In Advanced Liver Cancer
07 Mar 2025 //
BUSINESSWIRE
Evotec Advances Neuroscience Alliance with Bristol Myers Squibb
04 Mar 2025 //
CONTRACTPHARMA
BMS telegraphs 223 more job cuts in its home state of NJ
04 Mar 2025 //
FIERCE PHARMA
Bristol Myers Squibb Announces Dividend
03 Mar 2025 //
BUSINESSWIRE
Bristol Myers to Participate in Upcoming Investor Conferences
25 Feb 2025 //
BUSINESSWIRE
FDA Accepts BMS’ sBLA For Opdivo + Yervoy In MSI-High, Cancer
24 Feb 2025 //
BUSINESSWIRE
BioArctic`s global license agreement with Bristol Myers Squibb
20 Feb 2025 //
PR NEWSWIRE
BMS`s Opdivo scores overall survival triumph in NSCLC trial
20 Feb 2025 //
FIERCE PHARMA
BMS’ Opdivo Combo Shows OS Benefit In Resectable NSCLC
19 Feb 2025 //
BUSINESSWIRE
Rancho BioSciences, BMS Extend Single-Cell Consortium Partnership
18 Feb 2025 //
ACCESSWIRE
Five-Year Sotyktu Data Shows Safety In Plaque Psoriasis
18 Feb 2025 //
BUSINESSWIRE
